Mesenchymal stromal cells (MSCs) are an attractive option for cell therapy for type 1
diabetes mellitus (DM). These cells can be obtained from many sources, but bone marrow …

Over the past decade, there had been progress in the development of cell therapy for insulin-
dependent diabetes. Nevertheless, important hurdles that need to be overcome still remain …

BACKGROUND Progressive pancreatic β-cell dysfunction is a fundamental part of the
pathology of type 2 diabetes mellitus (T2DM). Cellular therapies offer novel opportunities for …

The incidence and prevalence of diabetes mellitus (DM) are increasing worldwide, and the
resulting cardiac complications are the leading cause of death. Among these complications …

Mesenchymal stem cells (MSCs) are adult stem cells (ASCs) known for repairing damaged
cells, exerting anti‐inflammatory responses and producing immunoregulatory effects that …

Abstract Aims/Introduction In recent years, mesenchymal cellular therapies have received
much attention in the treatment of diabetes. In this meta‐analysis, we aimed to evaluate the …

Tissue engineering (TE) has become a new effective solution to a variety of medical
problems, including diabetes. Mesenchymal stem cells (MSCs), which have the ability to …

Mesenchymal stem cells (MSCs) originating from the umbilical cord (UC) or Wharton's jelly
(WJ) have attracted substantial interest due to their potential to augment therapeutic …

Autophagy disruption suppresses insulin production and induces diabetes. The role of
autophagy in the differentiation of Wharton's jelly (WJ)-derived mesenchymal stem cells …

Human term placenta and other postpartum-derived biological tissues are promising
sources of perinatal cells with unique stem cell properties. Among the massive current …